Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VM902A in Osteoarthritis of the Knee
NCT02847702Phase 2Terminated
- Sponsor
- Purdue Pharma
- Start
- Aug 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VM-902A in knee osteoarthritis (OA), sponsored by Purdue Pharma. Started Aug 2016; status: terminated.
02
Drugs
VM-902A
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02847702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02847702.